| Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement (NCT03812328) | Tetherex Pharmaceuticals Corporation | 2019-02-20 |
| The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section (NCT03833895) | China International Neuroscience Institution | 2019-02-20 |
| Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients (NCT03823352) | Golden Biotechnology Corporation | 2019-02-20 |
| A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease (NCT03681067) | University of Birmingham | 2019-02-20 |
| Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Intensive Rehabilitation (NCT03906721) | Spaulding Rehabilitation Hospital | 2019-02-20 |
| Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma (NCT03846427) | BeiGene | 2019-02-19 |
| Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers (NCT03801083) | Udai Kammula | 2019-02-19 |
| A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis (NCT04152226) | DermBiont, Inc. | 2019-02-19 |
| Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate (NCT04110418) | Ain Shams University | 2019-02-19 |
| A Study of Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer (NCT03903887) | Sun Yat-sen University | 2019-02-19 |
| Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD (NCT03708237) | University of Alberta | 2019-02-19 |
| PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer (NCT03611712) | PhytoHealth Corporation | 2019-02-19 |
| A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma (NCT03891173) | Helix BioPharma Corporation | 2019-02-19 |
| A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT03832946) | Galecto Biotech AB | 2019-02-19 |
| Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) (NCT03769467) | Atara Biotherapeutics | 2019-02-19 |
| Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis (NCT03710941) | Regeneron Pharmaceuticals | 2019-02-19 |
| Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis (NCT03520647) | National Heart, Lung, and Blood Institute (NHLBI) | 2019-02-19 |
| Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma (NCT03784326) | M.D. Anderson Cancer Center | 2019-02-19 |
| Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections (NCT03931408) | University of Louisville | 2019-02-19 |
| A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer (NCT03904537) | Sun Yat-sen University | 2019-02-19 |
| The Effects of Topical Treatment With Clonidine + Pentoxifylline in Patients With Neuropathic Pain (NCT03342950) | Terence J. Coderre | 2019-02-19 |
| Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women (NCT03282799) | Catherine Anne Chappell | 2019-02-19 |
| PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 (NCT03655236) | Sun Pharma Advanced Research Company Limited | 2019-02-18 |
| Exploratory Study of ZG-801 for the Treatment of Hyperkalemia (NCT03799926) | Zeria Pharmaceutical | 2019-02-18 |
| A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer (NCT03425565) | University College, London | 2019-02-18 |
| Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc Disease (DDD) Unresponsive (NCT03737461) | University Hospital, Montpellier | 2019-02-18 |
| Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study) (NCT03873246) | Oyster Point Pharma, Inc. | 2019-02-18 |
| Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9 (NCT03744026) | CarThera | 2019-02-18 |
| Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV (NCT03141060) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-02-18 |
| PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma (NCT03850522) | Lene Meldgaard Knudsen | 2019-02-18 |
| A Study of LY900014 in a Medtronic Pump (NCT03760640) | Eli Lilly and Company | 2019-02-18 |
| Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa (NCT03529877) | RHEACELL GmbH & Co. KG | 2019-02-16 |
| Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss (NCT03603314) | Sensorion | 2019-02-15 |
| A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma (NCT03698019) | National Cancer Institute (NCI) | 2019-02-15 |
| Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA) (NCT03606590) | NovoCure Ltd. | 2019-02-15 |
| To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia (NCT03413384) | BrainX Corporation | 2019-02-15 |
| Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors (NCT03693846) | Abramson Cancer Center at Penn Medicine | 2019-02-15 |
| Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System Lymphoma (NCT03770416) | M.D. Anderson Cancer Center | 2019-02-15 |
| Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients (NCT03610724) | Novartis Pharmaceuticals | 2019-02-15 |
| Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection (NCT03839550) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-02-15 |
| First-line Therapy in Metastatic PDAC (NCT03487016) | Ludwig-Maximilians - University of Munich | 2019-02-15 |
| Metformin in Heart Failure Without Diabetes (NCT03331861) | Columbia University | 2019-02-15 |
| Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck (NCT03830385) | Sun Yat-sen University | 2019-02-15 |
| Corticosteroid Treatment in the Acute Phase of Caustic Ingestion Management (NCT03760354) | Assistance Publique - Hôpitaux de Paris | 2019-02-15 |
| Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia (NCT03896945) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-02-15 |
| The Comeback Study (NCT03691987) | University Hospital of North Norway | 2019-02-15 |
| Memantine and Post-mastectomy Neuropathic Pain (NCT03686774) | University Hospital, Clermont-Ferrand | 2019-02-15 |
| Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses (NCT03752307) | University of New Mexico | 2019-02-15 |
| Study Evaluating The Role of ClO2 on Mucositis for Pt. Undergoing Head/Neck Radiotherapy (NCT03602066) | University of Arizona | 2019-02-14 |
| A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers (NCT03843775) | Memorial Sloan Kettering Cancer Center | 2019-02-14 |
| Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment (NCT03329599) | Northern California Institute of Research and Education | 2019-02-14 |
| ImmunoPET With an Anti-CD8 Imaging Agent (NCT04029181) | University Medical Center Groningen | 2019-02-14 |
| Subjects With Non-Healing Venous Leg Ulcers Treated With Standard Care Plus Cryopreserved Human Umbilical Cord (TTAX01) (NCT03818828) | BioTissue Holdings, Inc | 2019-02-14 |
| Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003 (NCT03847974) | LIB Therapeutics LLC | 2019-02-14 |
| Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c (NCT04488107) | Ahon Pharmaceutical Co., Ltd. | 2019-02-14 |
| PDR001 Plus Imatinib for Metastatic or Unresectable GIST (NCT03609424) | Asan Medical Center | 2019-02-14 |
| The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population (NCT03918798) | Sintetica SA | 2019-02-14 |
| CFI-400945 in Patients With Advanced/Metastatic Breast Cancer (NCT03624543) | Canadian Cancer Trials Group | 2019-02-14 |
| A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) (NCT03988335) | Aristea Therapeutics, Inc. | 2019-02-13 |
| A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome (NCT03384420) | Minovia Therapeutics Ltd. | 2019-02-13 |
| Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B (NCT03575208) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2019-02-13 |
| Treatment of Chronic Itch in Patients Under Arsenic Exposure With Naloxone (NCT03751111) | Xiangya Hospital of Central South University | 2019-02-13 |
| A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer (NCT03803761) | National Cancer Institute (NCI) | 2019-02-13 |
| Study of TOP1630 for Dry Eye Syndrome (NCT03833388) | Topivert Pharma Ltd | 2019-02-13 |
| A Study of a Personalized Neoantigen Cancer Vaccine (NCT03639714) | Gritstone bio, Inc. | 2019-02-13 |
| Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma (NCT03500445) | University of Chicago | 2019-02-13 |
| Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) (NCT03797326) | Merck Sharp & Dohme LLC | 2019-02-12 |
| TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer (NCT04294264) | Rutgers, The State University of New Jersey | 2019-02-12 |
| IL-1 Signal Inhibition in Alcoholic Hepatitis (NCT03775109) | Imperial College London | 2019-02-12 |
| PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (NCT03817320) | Therapeutic Advances in Childhood Leukemia Consortium | 2019-02-12 |
| Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC (NCT03694236) | Yonsei University | 2019-02-12 |
| Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates (NCT03536117) | Biofabri, S.L | 2019-02-12 |
| Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC) (NCT03510871) | National Health Research Institutes, Taiwan | 2019-02-12 |
| 18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer (NCT03824275) | Columbia University | 2019-02-12 |
| Evaluate Safety and Efficacy of 25 mg Hydrocortisone Acetate Suppositories in Treatment of Internal Hemorrhoids (NCT03335774) | Nivagen Pharmaceuticals Inc. | 2019-02-12 |
| Saroglitazar Magnesium 4 mg in the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Women With PCOS (EVIDENCES VII) (NCT03617263) | Zydus Therapeutics Inc. | 2019-02-12 |
| A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis (NCT03831191) | Eli Lilly and Company | 2019-02-12 |
| A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. (NCT03910660) | BioXcel Therapeutics Inc | 2019-02-12 |
| Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer (NCT03847519) | Advaxis, Inc. | 2019-02-12 |
| Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer (NCT03642067) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-02-12 |
| P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma (NCT04233840) | National Taiwan University Hospital | 2019-02-12 |
| A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated (NCT03822832) | Boehringer Ingelheim | 2019-02-12 |
| Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge (NCT03838731) | Regeneron Pharmaceuticals | 2019-02-12 |
| A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer (NCT03879122) | Spanish Oncology Genito-Urinary Group | 2019-02-11 |
| Blocking Mifepristone Action With Progesterone (NCT03774745) | University of California, Davis | 2019-02-11 |
| Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC (NCT03732274) | MedPacto, Inc. | 2019-02-11 |
| A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients (NCT03801798) | Green Cross Corporation | 2019-02-11 |
| OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis (NCT03856645) | Okogen | 2019-02-11 |
| Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer (NCT03754933) | GeoVax, Inc. | 2019-02-11 |
| Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers (NCT02381470) | National University Hospital, Singapore | 2019-02-11 |
| Itacitinib + Everolimus in Hodgkin Lymphoma (NCT03697408) | University of Pennsylvania | 2019-02-11 |
| Evolocumab for PCSK9 Lowering in Early Acute Sepsis (The PLEASe Study) (NCT03869073) | University of British Columbia | 2019-02-11 |
| A Trial of Doxycycline vs. Standard Supportive Therapy in Newly-diagnosed Cardiac AL Amyloidosis Patients Undergoing Bortezomib-based Therapy (NCT03474458) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2019-02-11 |
| Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome (NCT03648879) | National Cancer Institute (NCI) | 2019-02-11 |
| A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma. (NCT03794440) | Innovent Biologics (Suzhou) Co. Ltd. | 2019-02-11 |
| Pupil Centroid Shift Compensation in Photorefractive Keratectomy Candidates (NCT03844178) | Shahid Beheshti University of Medical Sciences | 2019-02-10 |
| Pilot-Tart Cherry, Mitral Transcriptome, and POAF Incidence (NCT03793465) | University of Michigan | 2019-02-08 |
| Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer (NCT03827473) | University of Utah | 2019-02-08 |
| Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis (NCT03691493) | Emory University | 2019-02-08 |
| Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus Patients (NCT05241145) | iVeena Delivery Systems, Inc. | 2019-02-08 |